Found 8 matching trials
Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy
PHASE2Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality...
Location
Hospital Marques de Valdecilla
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells
PHASE1The present trial will consist of the treatment of 20 pediatric and adult H...
Location
University of Wisconsin Carbone Cancer Center
CMV-CTL for the Treatment of CMV Infection After HSCT
PHASE4Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
PHASE1This phase I/II trial studies the safety and toxicity of post-transplant tr...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Donor-Derived Viral Specific T-cells (VSTs)
PHASE1In this research study, the investigators want to learn more about the use ...
Location
Akron Children's Hospital
Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection
PHASE1To evaluate the safety and efficacy for treatment of persistent CMV infecti...
Location
Samsung Medical Center
Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease
N/AThis is an expanded access protocol designed to provide access of ATA230 to...
Status
No Longer Available
Location
Multiple Locations
CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency
NATreatment of CMV in a patient with profound combined immunodeficiency, who ...
Status
Active Not Recruiting
Location
Alberta Children's Hospital